(Q30660196)

English

Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

phase II clinical trial

0 references

Adaptive radiation therapy

0 references

author name string

Coughlin C

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Scott C

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Langer C

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Coia L

4

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Curran W

5

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Rubin P

6

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1351-1358

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

External irradiation followed by an interstitial high activity iodine-125 implant “boost” in the initial treatment of malignant gliomas: NCOG study 6G-82-2 gliomas: NCOG study 6H-82-2

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosurgery as part of the initial management of patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic basis for altered fractionation schemes.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Review: total doses in fractionated radiotherapy--implications of new radiobiological data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The high steepness of dose-response curves for late-responding normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic irradiation and brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

RELATION BETWEEN FIELD SIZE AND TOLERANCE OF RABBIT'S BRAIN TO ROENTGEN IRRADIATION (200KV) VIA A SLIT-SHAPED FIELD.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose, time and fractionation: A clinical hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nominal standard dose and the ret

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of adult supratentorial high grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901412-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)01412-7

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

release_lgmm5uv3avd4xnwhlxom7vghzy

1 reference

https://api.fatcat.wiki/v0/release/lgmm5uv3avd4xnwhlxom7vghzy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30660196&oldid=1985641915"